Febrile infection-related epilepsy syndrome: Clinical review and hypotheses of epileptogenesis

Neuropediatrics

Volumn 48, Issue 1, 2017, Pages 5-18

  Van Baalen, Andreas ^a   Vezzani, Annamaria ^b   Häusler, Martin ^c   Kluger, Gerhard ^d,e  

^a UNIVERSITY OF KIEL   (Germany)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d Epilepsy Center for Children and Adolescents   (Germany)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL OUTCOME; COMA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG RESISTANT EPILEPSY; ENTERIC FEEDING; EPIDEMIOLOGY; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; FEBRILE INFECTION RELATED EPILEPSY SYNDROME; GABAERGIC SYSTEM; HUMAN; IMMUNOPATHOLOGY; KETOGENIC DIET; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; REVIEW; SEIZURE; TREATMENT INDICATION; ACUTE FEBRILE ENCEPHALOPATHY; COMPLICATION; STATUS EPILEPTICUS;

ACUTE FEBRILE ENCEPHALOPATHY; DIAGNOSIS, DIFFERENTIAL; HUMANS; STATUS EPILEPTICUS;

EID: 85001874929     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0036-1597271     Document Type: Review

References (139)

1. van Baalen A, Häusler M, Boor R, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia 2010;51(7):1323-1328
2. Gupta P, Patel S, Ranjan R, Agrawal CS. An interesting case of super-refractory status epilepticus. Neurol India 2015;63(4): 628-629
3. van Baalen A, Häusler M, Plecko-Startinig B, et al. Febrile infection- related epilepsy syndromewithout detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics 2012;43(4): 209-216
4. Covanis A. Epileptic encephalopathies (including severe epilepsy syndromes). Epilepsia 2012;53(Suppl 4):114-126
5. Lyon G, Dodge PR, Adams RD. The acute encephalopathies of obscure origin in infants and children. Brain 1961;84:680-708
6. Sakuma H, Fukumizu M, Kohyama J. [Efficacy of anticonvulsants on acute encephalitis with refractory, repetitive partial seizures (AERRPS)]. No To Hattatsu 2001;33(5):385-390
7. Mikaeloff Y, Jambaqué I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo encephalitis. Epilepsy Res 2006;69(1):67-79
8. Kluger G, Granel M, Holthausen H. Refractory status epilepticus after non-specific infection in 3 previously healthy children. Abstracts of the 31st Annual Meeting of the Society for Neuropediatrics. Neuropediatrics 2012;36(2):P69
9. van Baalen A, Stephani U, Kluger G, Häusler M, Dulac O. FIRES: febrile infection responsive epileptic (FIRE) encephalopathies of school age. Brain Dev 2009;31(1):91, author reply 92-93
10. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51(10):2033-2037
11. Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain 2011;134(Pt 10):2802-2818
12. Nabbout R, Vezzani A, Dulac O, Chiron C. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol 2011;10(1):99-108
13. Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities? Epilepsia 2011;52(11):e185-e189
14. Striano P, Pezzella M, Brigati G, Minetti C. Lumping encephalopathies with inflammation-mediated status epilepticus: is there enough evidence? Epilepsy Behav 2011;20(3):592
15. Körtvelyessy P, Lerche H, Weber Y. FIRES and NORSE are distinct entities. Epilepsia 2012;53(7):1276
16. Appenzeller S, Helbig I, Stephani U, et al. Febrile infection-related epilepsy syndrome (FIRES) is not caused by SCN1A, POLG, PCDH19 mutations or rare copy number variations. Dev Med Child Neurol 2012;54(12):1144-1148
17. Pasca L, De Giorgis V, Macasaet JA, Trentani C, Tagliabue A, Veggiotti P. The changing face of dietary therapy for epilepsy. Eur J Pediatr 2016;175(10):1267-1276
18. Farias-Moeller R, Bartolini L, Pasupuleti A, Brittany Cines RD, Kao A, Carpenter JL. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care 2016; doi: 10.1007/s12028-016-0312-4
19. Jung DE, Kang HC, Lee JS, Lee EJ, Kim HD. Safety and role of ketogenic parenteral nutrition for intractable childhood epilepsy. Brain Dev 2012;34(8):620-624
20. Zupec-Kania B, Neal E, Schultz R, Roan ME, Turner Z, Welborn M. An update on diets in clinical practice. J Child Neurol 2013;28(8): 1015-1026
21. Lin JJ, Lin KL, Chan OW, Hsia SH, Wang HS; CHEESE Study Group. Intravenous ketogenic diet therapy for treatment of the acute stage of super-refractory status epilepticus in a pediatric patient. Pediatr Neurol 2015;52(4):442-445
22. Chiusolo F, Diamanti A, Bianchi R, et al. From intravenous to enteral ketogenic diet in PICU: A potential treatment strategy for refractory status epilepticus. Eur J Paediatr Neurol 2016;20(6):843-847
23. Byun JI, Chu K, Sunwoo JS, et al.Mega-dose phenobarbital therapy for super-refractory status epilepticus. Epileptic Disord 2015; 17(4):444-452
24. Vezzani A, Aronica E, Mazarati A, Pittman QJ. Epilepsy and brain inflammation. Exp Neurol 2013;244:11-21
25. Vezzani A, Friedman A, Dingledine RJ. The role of inflammation in epileptogenesis. Neuropharmacology 2013;69:16-24
26. Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr 2014;14 (1 Suppl)3-7
27. Vezzani A, French J, Bartfai T, BaramTZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7(1):31-40
28. Vezzani A, Maroso M, Balosso S, Sanchez MA, Bartfai T. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav Immun 2011;25(7):1281-1289
29. Miskin C, Hasbani DM. Status epilepticus: immunologic and inflammatory mechanisms. Semin Pediatr Neurol 2014;21(3): 221-225
30. Varadkar S, Cross JH. Rasmussen syndrome and other inflammatory epilepsies. Semin Neurol 2015;35(3):259-268
31. Riazi K, GalicMA, Pittman QJ. Contributions of peripheral inflammation to seizure susceptibility: cytokines and brain excitability. Epilepsy Res 2010;89(1):34-42
32. Galic MA, Riazi K, Pittman QJ. Cytokines and brain excitability. Front Neuroendocrinol 2012;33(1):116-125
33. Dubé CM, Ravizza T, Hamamura M, et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010;30(22):7484-7494
34. Vezzani A, Dingledine R, Rossetti AO. Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother 2015;15(9): 1081-1092
35. Vezzani A, Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 2015;96(Pt 0A) 70-82
36. De Simoni MG, Perego C, Ravizza T, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000;12(7):2623-2633
37. Aronica E, Boer K, van Vliet EA, et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 2007;26(3):497-511
38. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006;24(1):128-143
39. Wakamoto H, Takahashi Y, Ebihara T, et al. An immunologic case study of acute encephalitis with refractory, repetitive partial seizures. Brain Dev 2012;34(9):763-767
40. Sakuma H, Tanuma N, Kuki I, Takahashi Y, Shiomi M, Hayashi M. Intrathecal overproduction of proinflammatory cytokines and chemokines in febrile infection-related refractory status epilepticus. J Neurol Neurosurg Psychiatry 2015;86(7):820-822
41. Reschke CR, Henshall DC. microRNA and epilepsy. Adv Exp Med Biol 2015;888:41-70
42. Carpentier PA, Palmer TD. Immune influence on adult neural stem cell regulation and function. Neuron 2009;64(1):79-92
43. Vezzani A, Friedman A. Brain inflammation as a biomarker in epilepsy. Biomarkers Med 2011;5(5):607-614
44. Silveira G, de Oliveira AC, Teixeira AL. Insights into inflammation and epilepsy from the basic and clinical sciences. J Clin Neurosci 2012;19(8):1071-1075
45. Marchi N, Granata T, Janigro D. Inflammatory pathways of seizure disorders. Trends Neurosci 2014;37(2):55-65
46. Rosas-Ballina M, Tracey KJ. The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009;64(1):28-32
47. Patil SB, Roy AG, Vinayan KP. Clinical profile and treatment outcome of febrile infection-related epilepsy syndrome in South Indian children. Ann Indian Acad Neurol 2016;19(2): 188-194
48. El Sabbagh S, Lebre AS, Bahi-Buisson N, et al. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010;51(7):1225-1235
49. Bindoff LA. Mitochondrial function and pathology in status epilepticus. Epilepsia 2011;52(Suppl 8):6-7
50. Johnson KB, Michelson KA, Lyons TW, et al. Pediatric status epilepticus: how common is cerebrospinal fluid pleocytosis in the absence of infection? Seizure 2014;23(7):573-575
51. Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S. Effect of epileptic seizures on the cerebrospinal fluid-A systematic retrospective analysis. Epilepsy Res 2015;114:23-31
52. Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015;57(5): 431-440
53. Suleiman J, Brilot F, Lang B, Vincent A, Dale RC. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia 2013;54(6):1036-1045
54. Armangue T, Leypoldt F, Dalmau J. Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014;27(3):361-368
55. Antoine JC. Autoimmune encephalitis: paving the way for early diagnosis. Lancet Neurol 2016;15(4):349-350
56. Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15(4):391-404
57. Benson LA, Olson H, Gorman MP. Evaluation and treatment of autoimmune neurologic disorders in the pediatric intensive care unit. Semin Pediatr Neurol 2014;21(4):284-290
58. Salzberg SL, Breitwieser FP, Kumar A, et al. Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system. Neurol Neuroimmunol Neuroinflamm 2016; 3(4):e251
59. Cartagena AM, Young GB, Lee DH, Mirsattari SM. Reversible and irreversible cranial MRI findings associated with status epilepticus. Epilepsy Behav 2014;33:24-30
60. Nozaki F, Kumada T, Miyajima T, et al. Reversible splenic lesion in a patient with febrile infection-related epilepsy syndrome (FIRES). Neuropediatrics 2013;44(5):291-294
61. Agarwal A, Sabat S, Thamburaj K, Kanekar S. Hippocampal changes in febrile infection-related epilepsy syndrome (FIRES). Pol J Radiol 2015;80:391-394
62. Finetti C, Gerling CH, Schlump JU, Utz N, Schweiger T. Reversible cMRI changes after status epilepticus: two case reports and a review. Abstracts of the 42nd Annual Meeting of the Society for Neuropediatrics. Neuropediatrics 2016;47(S1):P01-20
63. Kobayashi K, Ouchida M, Okumura A, et al. Genetic seizure susceptibility underlying acute encephalopathies in childhood. Epilepsy Res 2010;91(2-3):143-152
64. Kobayashi K, Ohzono H, ShinoharaM, et al. Acute encephalopathy with a novel point mutation in the SCN2A gene. Epilepsy Res 2012;102(1-2):109-112
65. GableMS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012;54(7):899-904
66. Sato Y, Numata-Uematsu Y, Uematsu M, et al. Acute encephalitis with refractory, repetitive partial seizures: pathological findings and a new therapeutic approach using tacrolimus. Brain Dev 2016;38(8):772-776
67. Melvin JJ, Huntley Hardison H. Immunomodulatory treatments in epilepsy. Semin Pediatr Neurol 2014;21(3):232-237
68. Geva-Dayan K, Shorer Z, Menascu S, et al. Immunoglobulin treatment for severe childhood epilepsy. Pediatr Neurol 2012; 46(6):375-381
69. Nosadini M, Mohammad SS, Suppiej A, Sartori S, Dale RC; IVIG in Neurology Study Group. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome. Dev Med Child Neurol 2016;58(11):1180-1192
70. Aguglia U, Sueri C, Gasparini S, et al; Epilepsy Study Group of the Italian Neurological Society and of the Subcommission on Status Epilepticus of the Italian League Against Epilepsy. Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus. Epilepsia 2016;57(9):1527-1529
71. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on
72. children. Epilepsia 2011;52(11): 1956-1965
73. Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia 2011;52(Suppl 8):28-30
74. Sutter R, Kaplan PW. Can anesthetic treatment worsen outcome in status epilepticus? Epilepsy Behav 2015;49:294-297
75. Bellante F, Legros B, Depondt C, Créteur J, Taccone FS, Gaspard N. Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. J Neurol 2016;263(4):799-806
76. Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012;25(2): 173-178
77. Nangia S, Caraballo RH, Kang HC, Nordli DR, Scheffer IE. Is the ketogenic diet effective in specific epilepsy syndromes? Epilepsy Res 2012;100(3):252-257
78. Singh RK, Joshi SM, Potter DM, Leber SM, Carlson MD, Shellhaas RA. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics 2014; 134(5):e1431-e1435
79. Chang P, Augustin K, BoddumK, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 2016;139(Pt 2):431-443
80. Dupuis N, Curatolo N, Benoist JF, Auvin S. Ketogenic diet exhibits anti-inflammatory properties. Epilepsia 2015;56(7):e95-e98
81. Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004;35(4):250-252
82. Gofshteyn JS, Wilfong A, Devinsky O, et al. Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases. J Child Neurol 2016; doi: 10.1177/0883073816669450
83. Rosemergy I, Adler J, Psirides A. Cannabidiol oil in the treatment of super refractory status epilepticus. A case report. Seizure 2016; 35:56-58
84. Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 2014;55(6):791-802
85. Devinsky O, Marsh E, Friedman D, et al. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. Lancet Neurol 2016;15(3):270-278
86. Ogawa C, Natsume J, Yamamoto H, et al. Autopsy findings of a patient with acute encephalitis and refractory, repetitive partial seizures. Seizure 2016;35:80-82
87. Armangue T, Petit-PedrolM, Dalmau J. Autoimmune encephalitis in children. J Child Neurol 2012;27(11):1460-1469
88. Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 2016;12(1):1-13
89. Rivas-Coppola MS, Shah N, Choudhri AF, Morgan R, Wheless JW. Chronological evolution of magnetic resonance imaging findings in children with febrile infection-related epilepsy syndrome. Pediatr Neurol 2016;55:22-29
90. Dunleavy M, Shinoda S, Schindler C, et al. Experimental neonatal status epilepticus and the development of temporal lobe epilepsy with unilateral hippocampal sclerosis. Am J Pathol 2010;176(1): 330-342
91. Roch C, Leroy C, Nehlig A, Namer IJ. Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-dayold rats: an MRI approach using the lithium-pilocarpine model. Epilepsia 2002;43(10):1129-1136
92. Howell KB, Katanyuwong K, Mackay MT, et al. Long-term followup of febrile infection-related epilepsy syndrome. Epilepsia 2012; 53(1):101-110
93. Bausell R, Svoronos A, Lennihan L, Hirsch LJ. Recovery after severe refractory status epilepticus and 4 months of coma. Neurology 2011;77(15):1494-1495
94. Korff C, Fluss J, Valenza N, et al. Febrile infection responsive encephalopathy of school-age (FIRES)with unexpected favorable evolution. Epilepsia 2009;50(Suppl 12):84
95. Capovilla G, Wolf P, Beccaria F, Avanzini G. The history of the concept of epileptic encephalopathy. Epilepsia 2013;54 (Suppl 8):2-5
96. Saitoh M, Kobayashi K, Ohmori I, et al. Cytokine-related and sodium channel polymorphism as candidate predisposing factors for childhood encephalopathy FIRES/AERRPS. J Neurol Sci 2016; 368:272-276
97. Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia 2012;60(8):1258-1268
98. Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrumof diseases. Nat Rev Drug Discov 2012;11(8):633-652
99. Kenney DL, Kahoud RJ, Vezzani A, et al. Super-refractory status epilepticus and febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol 2016; doi: 10.1002/ ana.24806
100. Pillai SC, Mohammad SS, Hacohen Y, et al. Postencephalitic epilepsy and drug-resistant epilepsy after infectious and antibody- associated encephalitis in childhood: clinical and etiologic risk factors. Epilepsia 2016;57(1):e7-e11
101. Cianfoni A, Caulo M, Cerase A, et al. Seizure-induced brain lesions: a wide spectrum of variably reversible MRI abnormalities. Eur J Radiol 2013;82(11):1964-1972
102. Sarria-Estrada S, Toledo M, Lorenzo-Bosquet C, et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol 2014;69(8):795-803
103. Mohammad SS, Soe SM, Pillai SC, et al. Etiological associations and outcome predictors of acute electroencephalography in childhood encephalitis. Clin Neurophysiol 2016;127(10): 3217-3224
104. Baysal-Kirac L, Tuzun E, Altindag E, et al. Are there any specific EEG findings in autoimmune encephalitis? Clin EEG Neurosci 2016;47(3):224-234
105. Bigi S, Hladio M, Twilt M, Dalmau J, Benseler SM. The growing spectrum of antibody-associated inflammatory brain diseases in children. Neurol Neuroimmunol Neuroinflamm 2015;2(3):e92
106. Mazzuca M, Jambaque I, Hertz-Pannier L, et al. 18F-FDG PET reveals frontotemporal dysfunction in children with fever-induced refractory epileptic encephalopathy. J Nucl Med 2011; 52(1):40-47
107. Cross JH. Fever and fever-related epilepsies. Epilepsia 2012;53 (Suppl 4):3-8
108. Venkatesan A, Tunkel AR, Bloch KC, et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013;57(8): 1114-1128
109. Wolf NI, Rahman S, Schmitt B, et al. Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009;50(6):1596-1607
110. Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an underrecognized clinicoradiologic disorder. Mediators Inflamm 2015; doi: 10.1155/2015/792578
111. Specchio N, Marini C, Terracciano A, et al. Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations. Epilepsia 2011;52(7):1251-1257
112. Tsuji M, Mazaki E, Ogiwara I, et al. Acute encephalopathy in a patient with Dravet syndrome. Neuropediatrics 2011;42(2): 78-81
113. Elbers J, Halliday W, Hawkins C, Hutchinson C, Benseler SM. Brain biopsy in children with primary small-vessel central nervous system vasculitis. Ann Neurol 2010;68(5):602-610
114. Yamada K, Miura K, Hara K, et al. Awide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations. BMC Med Genet 2010;11:171
115. Tabarki B, Al-Shafi S, Al-Shahwan S, et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings. Neurology 2013;80(3):261-267
116. Karall D, Haberlandt E, Albrecht U, Rostasy K, Häberle J, Scholl- Bürgi S. Unrecognized citrullinemia mimicking encephalitis in a 14-year-old boy: unexpected result through the use of a standardized lumbar puncture protocol. Neuropediatrics 2012;43(2): 59-63
117. Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med 2006;32(12):2070-2076
118. Fernandez A, Lantigua H, Lesch C, et al. High-dose midazolam infusion for refractory status epilepticus. Neurology 2014;82(4): 359-365
119. Ueda R, Saito Y, Ohno K, et al. Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase. Brain Dev 2015;37(5):471-477
120. Shiloh-Malawsky Y, Fan Z, Greenwood R, Tennison M. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 2011;20(7):586-588
121. Ilvento L, Rosati A, Marini C, L'Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav 2015;49:343-346
122. Capizzi G, Vittorini R, Torta F, et al. Lidocaine treatment in refractory status epilepticus resulting from febrile infectionrelated epilepsy syndrome: a case report and follow-up. Neuropediatrics 2015;46(1):65-68
123. Lin JJ, Lin KL, Wang HS, Hsia SH, Wu CT. Effect of topiramate, in combinationwith lidocaine, and phenobarbital, in acute encephalitis with refractory repetitive partial seizures. Brain Dev 2009; 31(8):605-611
124. Chou IC, Lai HC, Tsai FJ, et al. Marked improvement in febrile infection-related epilepsy syndrome after lidocaine plus MgSO4 treatment in a 12-year-old girl. Epilepsy Behav Case Rep 2016; 6:6-9
125. Fugate JE, Burns JD, Wijdicks EF, Warner DO, Jankowski CJ, Rabinstein AA. Prolonged high-dose isoflurane for refractory status epilepticus: is it safe? Anesth Analg 2010;111(6): 1520-1524
126. Lin JJ, Lin KL, Hsia SH, Wang HS; CHEESE Study Group. Therapeutic hypothermia for febrile infection-related epilepsy syndrome in two patients. Pediatr Neurol 2012;47(6):448-450
127. Tan WW, Chan DWS, Lee JH, Thomas T, Menon AP, Chan YH. Use of magnesium sulfate infusion for the management of febrile illness-related epilepsy syndrome: a case series. Child Neurology Open 2015;2:1-5
128. Häusler M, Schoberer M, van Baalen A, et al. FIRES (febrile infection-related epilepsy syndrome) partially responsive to magnesium and dextromethorphan treatment. Abstracts of the 38th Annual Meeting of the Society of Neuropediatrics. Neuropediatrics 2012;43(2):PS19-06
129. Muehlebner A, Groeppel G, Pahs G, et al. Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res 2010;90(3):295-299
130. Vezzani A, Moneta D, Conti M, et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000; 97(21):11534-11539
131. Vezzani A, Moneta D, Richichi C, et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002;43(Suppl 5):30-35
132. Marchi N, Fan Q, Ghosh C, et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus. Neurobiol Dis 2009;33(2):171-181
133. Veiga AM, Moreno DC, Menéndez AIG, et al. Effectiveness of electroconvulsive therapy for refractory status epilepticus in febrile infection-related epilepsy syndrome. Neuropediatrics 2016. doi: 10.1055/s-0036-1584939
134. Wasterlain CG, Baldwin R, Naylor DE, Thompson KW, Suchomelova L, Niquet J. Rational polytherapy in the treatment of acute seizures and status epilepticus. Epilepsia 2011;52 (Suppl 8):70-71
135. Holzer FJ, Seeck M, Korff CM. Autoimmunity and inflammation in status epilepticus: fromconcepts to therapies. Expert Rev Neurother 2014;14(10):1181-1202
136. Specchio N, Fusco L, Claps D, et al. Childhood refractory focal epilepsy following acute febrile encephalopathy. Eur J Neurol 2011;18(7):952-961
137. Illingworth MA, Hanrahan D, Anderson CE, et al. Elevated VGKCcomplex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol 2011;53(11):1053-1057
138. Sivakumar S, Ibrahim M, Parker D Jr, Norris G, Shah A, Mohamed W. Clobazam: an effective add-on therapy in refractory status epilepticus. Epilepsia 2015;56(6):e83-e89
139. Palencia G, Martinez-Juarez IE, Calderon A, Artigas C, Sotelo J. Thalidomide for treatment of refractory epilepsy. Epilepsy Res 2010;92(2-3):253-257